Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Xiong Ying Miao"'
Autor:
Yan-Wen Zheng, Xiong-Ying Miao, Li Xiong, Bo Chen, Fan-Hua Kong, Jiang-Jiao Zhou, Zhong-Tao Liu, Yu Wen, Zi-Jian Zhang, Heng Zou
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Cholangiocarcinoma (CCA), which is highly malignant, shows a relatively poor prognosis, due to the insensitivity of the tumour to chemotherapy and radiotherapy. Photodynamic therapy (PDT) has become a promising palliative therapeutic option for patie
Externí odkaz:
https://doaj.org/article/993679abe4d1403d979ec9ea804af36b
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Underlying liver function is a major concern when applying surgical resection for hepatocellular carcinoma (HCC). We aimed to explore the capability of the albumin-bilirubin (ALBI) grade to predict post-hepatectomy liver failure (
Externí odkaz:
https://doaj.org/article/7ccae8d649d74fb984cfdbdb4e0b558b
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background The purpose of this case series is to investigate the relationship between splenic thickness (ST) and postoperative outcomes after hepatic resection in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) patients. Me
Externí odkaz:
https://doaj.org/article/8fb5b41124e8463fa3e4f236ea4edde7
Autor:
Qiong Zou, Xiong-Ying Miao, Zhengchun Wu, Zhulin Yang, Yuan Yuan, Li Xiong, Rushi Liu, Daiqiang Li
Publikováno v:
Cancer Management and Research. 12:221-232
Aim EphB3 and dysadherin are involved in tumorigenesis and progression of many neoplasms. However, the roles of EphB3 and dysadherin in extrahepatic cholangiocarcinoma (ECC) remain to be revealed. In this study, we aimed to evaluate the expression of
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
A precise and noninvasive method to predict posthepatectomy liver failure (PHLF) in clinical practice is still lacking. Liver fibrosis or cirrhosis accompanied with varying degrees of portal
A precise and noninvasive method to predict posthepatectomy liver failure (PHLF) in clinical practice is still lacking. Liver fibrosis or cirrhosis accompanied with varying degrees of portal
Autor:
Lu‑Feng Liang, En‑Xiang Zhou, Xiong‑Ying Miao, Qiong Zou, Gui‑Xiang Zeng, Zhu‑Lin Yang, Jing He Li, Dan‑Hua Zhang, Sen‑Lin Chen
Publikováno v:
Oncology Letters
Gallbladder cancer (GBC) is a rare but highly aggressive cancer for which no well-accepted prognostic biomarkers have been identified. Thymus cell antigen 1 (Thy1), also known as cluster of differentiation (CD)90, and integrin α6 (ITGA6), also known
Publikováno v:
Clinical and Translational Oncology. 18:352-359
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor of the pancreas with poor prognosis. The lack of understanding of the molecular mechanisms of PDAC and biomarkers for early diagnosis might be two of the reasons for the poor prognos
Autor:
Fan-Hua Kong, Qi-Fa Ye, Xiong-Ying Miao, Xi Liu, Si-Qi Huang, Li Xiong, Yu Wen, Zi-Jian Zhang
Publikováno v:
Theranostics; 2021, Vol. 11 Issue 11, p5464-5490, 27p
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 14:263-268
Background Portal hypertension is one of the most important clinical conditions that cause intraoperative intensive hemorrhage in cirrhotic patients undergoing liver transplantation. Pre-transplant portal decompression may reduce the intraoperative b
Autor:
Qiong Zou, Lufeng Liang, Zhu-Lin Yang, Ziru Liu, Daiqiang Li, Yuan Yuan, Xiong-Ying Miao, Guixiang Zeng, Jinghe Li, Senlin Chen
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:1441-1446
Squamous cell/adenosquamous carcinoma (SC/ASC) of the gallbladder are rare tumors and there are few clinical reports in the literature. Herein we report our clinical experience with 46 patients with SC/ASC and 80 with adenocarcinoma (AC). Expression